Quarterly report pursuant to Section 13 or 15(d)

Nature of Business and Significant Accounting Policies (Details)

v3.22.4
Nature of Business and Significant Accounting Policies (Details)
 3 Months Ended 6 Months Ended 12 Months Ended
May 17, 2022
USD ($)
Oct. 20, 2021
USD ($)
a
Jun. 14, 2021
USD ($)
Feb. 26, 2020
Oct. 31, 2018
USD ($)
Jun. 27, 2018
USD ($)
Feb. 28, 2018
USD ($)
shares
Dec. 04, 2017
USD ($)
Apr. 29, 2015
shares
Dec. 10, 2014
shares
Nov. 12, 2014
shares
Nov. 30, 2022
USD ($)
Nov. 30, 2021
USD ($)
Nov. 30, 2022
USD ($)
shares
Nov. 30, 2021
USD ($)
shares
May 31, 2022
USD ($)
May 31, 2021
USD ($)
May 31, 2020
USD ($)
Sep. 15, 2022
USD ($)
Aug. 31, 2022
Mar. 14, 2022
USD ($)
Jan. 04, 2022
USD ($)
Apr. 30, 2021
USD ($)
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Stockholders' Equity Note, Stock Split, Conversion Ratio                   0.625                          
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions             10.00%                                
Debt Instrument, Face Amount                                     $ 18,846,721   $ 359,900 $ 2,500,000 $ 6,229,672
Asset Impairment Charges                                 $ 2,498,706            
Financing Receivable, after Allowance for Credit Loss, Current     $ 3,000,000   $ 5,000,000                                    
Proceeds from Collection of Notes Receivable                           $ 348,165 $ 1,696,328 $ 2,740,820              
Lessee, Operating Lease, Term of Contract 9 years 9 years                                          
Operating Lease, Expense                       $ 83,520 $ 126,430 207,908 249,374                
Cash and Cash Equivalents, at Carrying Value                       808,592   808,592   2,551,859 1,665,263            
Accounts Receivable, Credit Loss Expense (Reversal)                       0 129 0 129                
Goodwill                       557,896   557,896   $ 557,896              
Net Income (Loss) Attributable to Noncontrolling Interest                       10,587 (3,500) (173,060) (3,500)                
Advertising Expense                       175,232 341,872 398,125 788,538                
Research and Development Expense                       $ 683 $ 9,908 $ 683 $ 10,508                
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                           42,653,147 18,857,739                
Warrant [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                           21,962,699 1,656,467                
Equity Unit Purchase Agreements [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                           256,550 760,323                
Convertible Debt Securities [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                           20,403,898 16,423,449                
Stock Payable [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                           30,000 17,500                
Minimum [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Lessee, Operating Lease, Term of Contract                       1 year   1 year                  
Operating Lease, Expense $ 3,500 $ 3,500                                          
Maximum [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Lessee, Operating Lease, Term of Contract                       10 years 6 months   10 years 6 months                  
Oasis LLCs [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Debt Instrument, Face Amount             $ 4,000,000                                
Kealii Okamalu, LLC [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Equity Method Investment, Ownership Percentage   50.00%                                   50.00%      
Quinn River Joint Venture Agreement [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Equity Method Investment, Ownership Percentage   50.00%                                          
Lessee, Operating Lease, Term of Contract   10 years                                          
Lessee, Operating Lease, Renewal Term   10 years                                          
Joint Venture, Description   ” The Company will provide up to 10,000 square feet of warehouse space at its Las Vegas facility for the Quinn River Joint Venture product, and has preferred vendor status, including the right to purchase cannabis flower and the business’s cannabis trim at favorable prices. Kealii Okamalu is expected to contribute up to $6 million (the “Invested Amount”) towards the construction of the Cultivation Facility and the working capital for the Quinn River Joint Venture. This amount will be repaid from the portion of the net profits of the Quinn River Joint Venture otherwise payable to CSI and the Tribe at the rate of $750,000 per quarter for eight quarters. After repayment of the Invested Amount, Kealii Okamalu will receive one-third of the net profits of the Quinn River Joint Venture.                           Kealii Okamalu is expected to ultimately contribute $6 million towards the construction of the Cultivation Facility and the working capital for the Quinn River Joint Venture. This amount will be repaid from a portion of the net income of the Quinn River Joint Venture otherwise payable to CSI and the Tribe at the rate of $750,000 per quarter for eight quarters. After repayment to Kealii Okamalu of the initial investment amount of approximately $6 million, Kealii Okamalu will receive one-third of the net profits of the Quinn River Joint Venture.              
Quinn River Joint Venture Agreement [Member] | Minimum [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Area of Land (in Acres) | a   20                                          
Operating Lease, Expense   $ 3,500                                          
Quinn River Joint Venture Agreement [Member] | Maximum [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Area of Land (in Acres) | a   30                                          
Principal [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Asset Impairment Charges                                 2,497,884            
Accrued Interest [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Asset Impairment Charges                                 822            
Reverse Merger with CLS Labs [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Stock Issued During Period, Shares, New Issues (in Shares) | shares                 3,750,000                            
Oasis Acquisition [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Payments to Acquire Businesses, Gross             6,200,000                                
Liabilities Assumed             $ 204,457                                
Oasis Acquisition [Member] | Oasis LLCs [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners           90.00%                                  
Oasis Acquisition [Member] | Deposit [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Payments to Acquire Businesses, Gross               $ 250,000                              
Oasis Acquisition [Member] | Additional Payments [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Payments to Acquire Businesses, Gross               $ 1,800,000                              
Oasis LLCs [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares) | shares             5,514,706                                
Oasis LLCs [Member] | Oasis LLCs [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Payments to Acquire Businesses, Gross           $ 5,995,543                                  
In Good Health [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Payments to Acquire Businesses, Gross         35,000,000                                    
Business Combination, Consideration Transferred         47,500,000                                    
Business Combination, Consideration Transferred, Liabilities Incurred         7,500,000                                    
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned         5,000,000                                    
Business Combination, Contingent Consideration, Liability         $ 2,500,000                                    
Interest Rate, Default       15.00% 15.00%                                    
Proceeds from Collection of Notes Receivable                                 $ 1,696,765 $ 1,425,000          
In Good Health [Member] | Principal [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Proceeds from Collection of Notes Receivable                           $ 333,333   $ 2,666,670              
In Good Health [Member] | Accrued Interest [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Proceeds from Collection of Notes Receivable                           $ 14,832   $ 74,150              
In Good Health [Member] | Due And Payable On Or Before June 21, 2021 [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Proceeds from Collection of Notes Receivable     500,000                                        
In Good Health [Member] | Due And Payable On Or Before July 12, 2021 [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Proceeds from Collection of Notes Receivable     500,000                                        
In Good Health [Member] | Due And Payable In12 Monthly Installments [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Proceeds from Collection of Notes Receivable     $ 2,000,000                                        
Shares of CLS Holdings USA, Inc. [Member] | CLS Labs, Inc. [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Subsidiary or Equity Method Investee, Cumulative Number of Shares Issued for All Transactions (in Shares) | shares                   1,562,500 2,500,000                        
Shares of CLS Holdings USA, Inc. [Member] | CLS Labs, Inc. [Member]                                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                              
Equity Method Investment, Ownership Percentage                     55.60%